Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
Authors
Keywords
Hypoxia, Pristimerin, SPHK-1, Prostate cancer, HIF-1α
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-02
DOI
10.1186/s12885-016-2730-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coumestrol suppresses hypoxia inducible factor 1α by inhibiting ROS mediated sphingosine kinase 1 in hypoxic PC-3 prostate cancer cells
- (2014) Sung-Yun Cho et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells
- (2014) Sun-Mi Cho et al. BMC Complementary and Alternative Medicine
- Anticancer Activity of Pristimerin in Epidermal Growth Factor Receptor 2-Positive SKBR3 Human Breast Cancer Cells
- (2013) Jin Sun Lee et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Pristimerin Inhibits Breast Cancer Cell Migration by Up-regulating Regulator of G Protein Signaling 4 Expression
- (2012) Xian-Min Mu et al. Asian Pacific Journal of Cancer Prevention
- Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
- (2012) Xianmin Mu et al. MOLECULES
- Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
- (2012) Yongwei Wang et al. PLoS One
- Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells
- (2011) Sung-Yun Cho et al. JOURNAL OF PINEAL RESEARCH
- 1,2,3,4,6-Penta-O-galloly-beta-D-glucose Suppresses Hypoxia-Induced Accumulation of Hypoxia-Inducible Factor-1α and Signaling in LNCaP Prostate Cancer Cells
- (2010) Ki-Young Park et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
- (2010) Zhongzheng Lu et al. Molecular Cancer
- Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
- (2010) Robert B. Hamanaka et al. TRENDS IN BIOCHEMICAL SCIENCES
- When the Sphingosine Kinase 1/Sphingosine 1-Phosphate Pathway Meets Hypoxia Signaling: New Targets for Cancer Therapy
- (2009) I. Ader et al. CANCER RESEARCH
- Targeting Vascular Endothelial Growth Factor in Renal Cell Carcinoma
- (2009) Nilay S. Patel et al. TUMOR BIOLOGY
- Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1 during Hypoxia in Human Cancer Cells
- (2008) I. Ader et al. CANCER RESEARCH
- Downregulating sphingosine kinase-1 for cancer therapy
- (2008) Olivier Cuvillier EXPERT OPINION ON THERAPEUTIC TARGETS
- Hypoxia in prostate cancer: observation to intervention
- (2008) Yaacov Richard Lawrence et al. LANCET ONCOLOGY
- Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells
- (2008) Patricia Marçal da Costa et al. TOXICOLOGY IN VITRO
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More